Helicobacter Infection Clinical Trial
Official title:
A Prospective, Single-center, Open-label, Clinical Trial to Compare the 10-day Sequential Therapy and 7-day Culture Based Tailored Therapy for the Eradication of Helicobacter Pylori
To compare the eradication success rate between 10-days sequential therapy and 7-days tailored therapy based on H. pylori culture and antimicrobial susceptibility testing.
As increasing antimicrobial resistance in Korea, the effectiveness of empirical Helicobacter pylori (H. pylori) therapies have been declined. Recently, 10-day sequential therapy was not sufficient to overcome tough situation for H. pylori eradication. Thus, in this study, the investigators evaluated the efficacy of H. pylori eradication between a 7 days tailored therapy (7 day PPI based triple therapy, bismuth quadruple therapy or moxifloxacin contained triple therapy) for H. pylori infection based on the results of antibiotics resistance by using H. pylori culture and minimal inhibitory concentration (MIC) and the 10 day sequential therapy for the first eradication of H. pylori infection, and the investigators analyzed the prevalence of the antibiotic resistance in the tailored therapy group. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02711176 -
Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection
|
Phase 4 | |
| Completed |
NCT00656968 -
Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection
|
Phase 4 | |
| Completed |
NCT00841854 -
Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication
|
Phase 4 | |
| Completed |
NCT02051348 -
Study of Pylopass Versus Placebo in Subjects Who Are Helicobacter Pylori Carriers and With Mild Indigestion
|
Phase 2/Phase 3 | |
| Completed |
NCT02349685 -
The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori
|
N/A | |
| Recruiting |
NCT01723059 -
Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection
|
N/A | |
| Terminated |
NCT02359331 -
The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection
|
N/A | |
| Completed |
NCT01163435 -
Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication
|
Phase 4 |